ClinicalTrials.Veeva

Menu
R

Radin Cardiovascular Medical Group | Newport Beach, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apixaban
Milvexian
Maridebart Cafraglutide
Iron
Inclisiran
sodium

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian
Status recently updated

V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous co...

Not yet enrolling
Enrolling
Peripheral Endovascular Intervention
Percutaneous Coronary Intervention
Drug: Normal Saline (Placebo)
Drug: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF...

Enrolling
Heart Failure With Preserved Ejection Fraction
Obesity
Drug: Placebo
Drug: Maridebart cafraglutide

Trial sponsors

Janssen (J&J Innovative Medicine) logo
American Regent logo
Amgen logo
Bayer logo
Duke University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems